These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 3111680)

  • 1. Prostaglandin H synthase-catalyzed metabolism and DNA binding of 2-naphthylamine.
    Boyd JA; Eling TE
    Cancer Res; 1987 Aug; 47(15):4007-14. PubMed ID: 3111680
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DNA adducts formed by ring-oxidation of the carcinogen 2-naphthylamine with prostaglandin H synthase in vitro and in the dog urothelium in vivo.
    Yamazoe Y; Miller DW; Weis CC; Dooley KL; Zenser TV; Beland FA; Kadlubar FF
    Carcinogenesis; 1985 Sep; 6(9):1379-87. PubMed ID: 3928186
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative effects of prostaglandin H synthase-catalyzed binding of two 5-nitrofuran urinary bladder carcinogens.
    Zenser TV; Palmier MO; Mattammal MB; Bolla RI; Davis BB
    J Pharmacol Exp Ther; 1983 Oct; 227(1):139-43. PubMed ID: 6413679
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic oxidation of carcinogenic arylamines by rat, dog, and human hepatic microsomes and by purified flavin-containing and cytochrome P-450 monooxygenases.
    Hammons GJ; Guengerich FP; Weis CC; Beland FA; Kadlubar FF
    Cancer Res; 1985 Aug; 45(8):3578-85. PubMed ID: 4016738
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro bioactivation of phenytoin to a reactive free radical intermediate by prostaglandin synthetase, horseradish peroxidase, and thyroid peroxidase.
    Kubow S; Wells PG
    Mol Pharmacol; 1989 Apr; 35(4):504-11. PubMed ID: 2539558
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence for peroxidase-mediated metabolism of cyclophosphamide.
    Kanekal S; Kehrer JP
    Drug Metab Dispos; 1993; 21(1):37-42. PubMed ID: 8095224
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prostaglandin H synthase-catalyzed ring oxygenation of 2-naphthylamine: evidence for two distinct oxidation pathways.
    Curtis JF; Tomer K; McGown S; Eling TE
    Chem Res Toxicol; 1995 Sep; 8(6):875-83. PubMed ID: 7492737
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Arachidonic acid-dependent peroxidative activation of carcinogenic arylamines by extrahepatic human tissue microsomes.
    Flammang TJ; Yamazoe Y; Benson RW; Roberts DW; Potter DW; Chu DZ; Lang NP; Kadlubar FF
    Cancer Res; 1989 Apr; 49(8):1977-82. PubMed ID: 2495173
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Generation of free radicals and induction of DNA adducts by activation of heterocyclic aromatic amines via different metabolic pathways in vitro.
    Moonen HJ; Briedé JJ; van Maanen JM; Kleinjans JC; de Kok TM
    Mol Carcinog; 2002 Dec; 35(4):196-203. PubMed ID: 12489111
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prostaglandin H synthase-1-catalyzed bioactivation of neurotransmitters, their precursors, and metabolites: oxidative DNA damage and electron spin resonance spectroscopy studies.
    Gonçalves LL; Ramkissoon A; Wells PG
    Chem Res Toxicol; 2009 May; 22(5):842-52. PubMed ID: 19374330
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic activation of carcinogenic aromatic amines by dog bladder and kidney prostaglandin H synthase.
    Wise RW; Zenser TV; Kadlubar FF; Davis BB
    Cancer Res; 1984 May; 44(5):1893-7. PubMed ID: 6424934
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence for activation of carcinogenic o-anisidine by prostaglandin H synthase: 32P-postlabelling analysis of DNA adduct formation.
    Stiborová M; Schmeiser HH; Breuer A; Frei E
    Gen Physiol Biophys; 2001 Sep; 20(3):267-79. PubMed ID: 11765217
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prostaglandin H synthase-catalyzed bioactivation of amphetamines to free radical intermediates that cause CNS regional DNA oxidation and nerve terminal degeneration.
    Jeng W; Ramkissoon A; Parman T; Wells PG
    FASEB J; 2006 Apr; 20(6):638-50. PubMed ID: 16581972
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolism of aromatic amines by prostaglandin H synthase.
    Boyd JA; Eling TE
    Environ Health Perspect; 1985 Dec; 64():45-51. PubMed ID: 3938394
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prostaglandin hydroperoxidase-dependent oxidation of phenylbutazone: relationship to inhibition of prostaglandin cyclooxygenase.
    Hughes MF; Mason RP; Eling TE
    Mol Pharmacol; 1988 Aug; 34(2):186-93. PubMed ID: 2842654
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peroxidase-catalyzed metabolism of etoposide (VP-16-213) and covalent binding of reactive intermediates to cellular macromolecules.
    Haim N; Nemec J; Roman J; Sinha BK
    Cancer Res; 1987 Nov; 47(22):5835-40. PubMed ID: 3117357
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Local carcinogenicity, rates of absorption, extent and persistence of macromolecular binding, and acute histopathological effects of N-hydroxy-1-naphthylamine and N-hydroxy-2-naphthylamine.
    Dooley KL; Beland FA; Bucci TJ; Kadlubar FF
    Cancer Res; 1984 Mar; 44(3):1172-7. PubMed ID: 6692401
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Formation of DNA adducts by the carcinogen N-hydroxy-2-naphthylamine.
    Kadlubar FF; Unruh LE; Beland FA; Straub KM; Evans FE
    Natl Cancer Inst Monogr; 1981 Dec; (58):143-52. PubMed ID: 6176869
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prostaglandin H synthase-catalyzed oxidation of all-trans- and 13-cis-retinoic acid to carbon-centered and peroxyl radical intermediates.
    Freyaldenhoven MA; Lloyd RV; Samokyszyn VM
    Chem Res Toxicol; 1996 Jun; 9(4):677-81. PubMed ID: 8831809
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Free radical-mediated oxidative DNA damage in the mechanism of thalidomide teratogenicity.
    Parman T; Wiley MJ; Wells PG
    Nat Med; 1999 May; 5(5):582-5. PubMed ID: 10229238
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.